J&J shares poised to gain-Barron’s

NEW YORK, May 2 (BestGrowthStock) – Johnson & Johnson (JNJ.N: )
shares should rise 10 percent to 20 percent within a year or
two from earnings growth, a strong product pipeline and a solid
balance sheet, according to Barron’s May 3 edition.

Barron’s says that having survived a difficult 2009, the
company’s main goal now is to boost sales.

Separately, Johnson & Johnson on Friday announced a recall
of a host of infants and children’s medicines, including
Children’s Tylenol and Zyrtec.

Stock Market News

J&J shares poised to gain-Barron’s